Parvovirus B 19 (PVB19) induced pure red cell aplasia (PRCA) in immunocompromised patient after liver transplantation

Collegium Antropologicum

Volumn 34, Issue 1, 2010, Pages 271-274

  Mrzljak, Anna ^a,b   Kardum Skelin, Ika ^a,b   Cvrlje, Vesna Čolić ^a,b   Kanižaj, Tajana Filipec ^a,b   Šušterčić, Dunja ^a   Guštin, Denis ^a   Kocman, Branislav ^a  

^a University of Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Liver transplantation; Parvovirus B19 (PVB19); Pure red cell aplasia (PRCA)

Indexed keywords

EOSIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MAY GRUNWALD GIEMSA; MAY-GRUNWALD GIEMSA; METHYLENE BLUE;

ARTICLE; BIOPSY; CASE REPORT; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PARVOVIRUS INFECTION; PATHOLOGY; POSTOPERATIVE COMPLICATION; PURE RED CELL ANEMIA; VIROLOGY; VIRUS LOAD;

BIOPSY; EOSINE YELLOWISH-(YS); HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; METHYLENE BLUE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POSTOPERATIVE COMPLICATIONS; RED-CELL APLASIA, PURE; VIRAL LOAD;

EID: 77952530651     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. FISCH P, HANDGRETINGER R, SCHAEFER HE, Br J Haematol, 111 (2000) 1010.
2. TING-BO L, DONG-LIN L, JUN Y, XUE-LI B, LIANG L, SHI-GUO X, WEI-LIN W, YAN S, MIN Z, SHU-SEN Z, World J Gastroenterol, 13 (2007) 2007.
3. MOUTHON L, GUILLEVIN L, TELLIER Z, Autoimmun Rev, 4 (2005) 264.
4. DJALDETTI M, BLAY A, BERGMAN M, SALMAN H, BESSLER H, Biomed Pharmacother, 57 (2003) 326.
5. AGRAWAL A, PARROTT NR, RIAD HN, AUGUSTINE T, Transplant Proc, 36 (2004) 2689.
6. HODO Y, TSUJI K, MIZUKOSHI E, YAMASHITA T, SAKAI A, NAKAMOTO Y, HONDA M, KANEKO S, Transpl Int, 19 (2006) 170.
7. GREGOOR PS, WEIMAR W, Am J Transplant, 5 (2005) 195.
8. THOMPSON DF, GALES MA, Pharmacotherapy, 16 (1996) 1002.
9. ENGELEN W, VERPOOTEN GA, VAN der PLANKEN M, HELBERT MF, BOSMANS JL, DE BROE ME, Clin Nephrol, 60 (2003) 119.
10. NOSARI A, MARBELLO L, DE CARLIS LG, DE GASPERI A, MUTI G, MANCINI V, MORRA E, Int J Hematol, 79 (2004) 130.
11. ELIMELAKH M, DAYTON V, PARK KS, GRUESSNER AC, SUTHERLAND D, HOWE RB, REDING MT, EASTLUND T, VAN BURIK JA, SINGLETON TP, GRUESSNER RW, KEY NS, Haematologica, 92 (2007) 1029.
12. CASADEVALL N, NATAF J, VIRON B, KOLTA A, KILADJIAN JJ, MARTIN-DUPONT P, MICHAUD P, PAPO T, UGO V, TEYSSANDIER I, VARET B, MAYEUX P, N Engl J Med, 346 (2002) 469.
13. COSSART YE, FIELD AM, CANT B, WIDDOWS D, Lancet, 1 (1975) 72.
14. KAUFMANN B, SIMPSON AA, ROSSMANN MG, Proc Natl Acad Sci, 101 (2004) 11628.
15. CHORBA T, COCCIA P, HOLMAN RC, TATTERSALL P, ANDERSON LJ, SUDMAN J, YOUNG NS, KURCZYNSKI E, SAARINEN UM, MOIR RJ, Infect Dis, 154 (1986) 383.
16. AZZI A, MORFINI M, MANNUCCI PM, Transfus Med Rev, 13 (1999) 194.
17. YOUNG NS, BROWN KE, N Engl J Med, 350 (2004) 586.
18. HEEGAARD ED, BROWN KE, Clin Microbiol Rev, 15 (2002) 485.
19. MOUTHON L, GUILLEVIN L, TELLIER Z, Autoimmun Rev, 4 (2005) 264.
20. METALLIDIS S, PAPAIOANNOU M, BOKOLAS G, KOLLARAS P, GOGOU V, NIKOLAIDIS P, Clin Nephrol, 71 (2009) 196.